Critical Care

Critical Care, a unit of Piramal Pharma, leads the way as a global leader in the field of anesthesia. ‘Save lives with innovative critical care solutions’ is much more than a purpose statement to us. Determined efforts and a solemn commitment towards the critical care fraternity has helped us grow steadfastly and gain prominence in international markets.

Today, we are the world's third largest producers of Inhaled Anesthetics and are extensively present across Europe and, USA. Our portfolio includes Inhalation Anesthetics such as Halothane, Isoflurane and Sevoflurane, as well as critical care products like Propofol and Plasma Volume Expanders like Polygeline.

Our focus and constant resolve towards qualitative production has resulted in regulatory approvals attributed to our manufacturing plants. Additionally, their strategic location enables us to supply products worldwide with great flexibility, helping us adhere to our commitment of providing uninterrupted delivery.

The Critical Care division was established in 2002, when Piramal Group acquired ICI India Ltd., followed by a string of other acquisitions of long-established manufacturers of eminent and trusted products. While most of our major operations take place in USA, our core strength lies in our culturally diverse team of 350 members across 20 nationalities, based out of 16 countries globally.

Visit Website

Pharma Solutions

Pharma Solutions is one of the largest manufacturing companies in the world that provides tractability and scalability of operations.

Read More

Consumer Products

The healthcare vertical has a Consumer Product Division, and is one of the fastest emerging players in the Domestic Consumer Healthcare market.

Read More

Imaging

Providing innovative diagnostic imaging agents, the Imaging Division aims to serve patients better, using world-class technology through our subsidiary.

Read More

PhytoMedicines™

PhytoMedicine™ develops and markets standardised healthcare solutions derived from natural sources such as plants.

Read More